CJC-1295 Research for Muscle Growth
An evidence-based overview of research examining CJC-1295 in the context of muscle growth. This page synthesizes findings from peer-reviewed literature.
Research Summary
CJC-1295's GH-releasing effects have generated interest for potential muscle-building applications. Growth hormone promotes protein synthesis and may enhance muscle recovery and hypertrophy. Phase 1 studies showed sustained IGF-1 elevations, which is the primary mediator of GH's anabolic effects on muscle tissue. The extended half-life of CJC-1295 DAC provides prolonged exposure to elevated GH/IGF-1. No clinical trials have evaluated CJC-1295 specifically for muscle growth or athletic performance. The peptide is prohibited by WADA for athletic competition.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Muscle Growth
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. CJC-1295 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.